[Production of infectious hepatitis C virus in cell culture].
Hepatitis C virus (HCV) is a major public health problem, infecting an estimated 170 million people worldwide. Current therapy for HCV-related chronic hepatitis is based on the use of interferon. However, virus clearance rates are insufficient. Investigations to develop the anti-viral therapy or to understand the life cycle of this virus have been hampered by the lack of viral culture systems. We isolated the JFH-1 strain from a patient with fulminant hepatitis, and the JFH-1 subgenomic replicon could replicate efficiently in culture cell without adaptive mutation. Recently, we developed the HCV infection system in culture cells with this JFH-1 strain. The full-length JFH-1 RNA was transfected into Huh7 cells. Subsequently, viral RNA efficiently replicated in transfected cells and viral particles were secreted. Furthermore, secreted virus displayed infectivity for naive Huh7 cells. This system provides a powerful tool for studying the viral life cycle and constructing anti-viral strategies.
Department of Microbiology, Tokyo Metropolitan Institute for Neuroscience, Tokyo.
Takanobu
T
Kato
Takaji
T
Wakita
D000818:Animals; D000998:Antiviral Agents; D002478:Cells, Cultured; D015195:Drug Design; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics / Q000502:physiology*; D006801:Humans; D008099:Liver / Q000821:virology*; D012093:Replicon; D014773:Virology / Q000379:methods*; D014779:Virus Replication
D000998:Antiviral Agents